PATENT CLAIM ANALYSIS

Application Number: 15755752
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-02
Patent Classification: ["424", "134100"]

Abstract:
The present invention provides an ACVR1-Fc fusion protein, a nucleic acid sequence encoding said fusion protein, a vector or a host cell comprising said encoding sequence, a method for producing said fusion protein, and use of any of the above in prevention and/or treatment of diseases or conditions associated with ACVR1 abnormality (e.g. ACVR1 mutation and/or over-activation).

Claim (Index 3):
The fusion protein of  claim 1 , wherein the fusion protein is selected from the group consisting of:\n a sequence having SEQ ID NO: 8; a sequence having one or more amino acid deletions, substitutions, or insertions with the sequence shown in SEQ ID NO: 8, and having the same biological activity as the sequence shown in SEQ ID NO: 8; and a sequence having at least 90% homology to the sequence shown in SEQ ID NO: 8 and having the same sequence as shown in SEQ ID NO: 8 sequences that have the same biological activity.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 99.0
- Lexical Diversity: 1.44444
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15300088', '14521143', '13654208', '12296275', '11716794']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8046374011784099
- 35 USC 102 Novelty (BERT): 0.5285759203700837
- Combined Prediction Score: 0.7770312530975773
- Mean Citation Score: 330.693196
- Max Citation Score: 359.5958
- Similarity Product: 253.0732011820912

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test